12:49 PM
Dec 19, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Cognitive dysfunction

Patient sample and mouse studies suggest inhibiting HMGB1 or reactive oxygen species (ROS) could help treat necrotizing enterocolitis-associated cognitive impairments. In infants with necrotizing enterocolitis, serum levels of HMGB1 and brain levels of ROS were higher than in healthy infants. In...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >